4 Healthcare Stocks for Investors to Check Out

GlaxoSmithKline (NYSE:GSK): Closing price $44.28

On Wednesday, GlaxoSmithKline and Theravance (NASDAQ:THRX) reported the submission of a regulatory application in the European Union for the investigational once-daily LAMA/LABA combination medicine, UMEC/VI, for patients suffering from chronic obstructive pulmonary disease . On December 18th, the firm announced the submission of a regulatory application with the FDA  for UMEC/VI.

gsk